<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-56FZ7G');</script><!--End Google Tag Manager--><title>Thionated organic compounds as emerging heavy-atom-free photodynamic therapy agents  - Chemical Science (RSC Publishing) DOI:10.1039/D0SC04747C</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2020/sc/d0sc04747c"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":63,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Luis A. Ortiz-Rodríguez"/><meta name="DC.Creator" content="Carlos E. Crespo-Hernández"/><meta name="DC.title" content="Thionated organic compounds as emerging heavy-atom-free photodynamic therapy agents "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2020/10/28"/><meta name="DC.Identifier" scheme="doi" content="10.1039/D0SC04747C"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Thionated organic compounds as emerging heavy-atom-free photodynamic therapy agents "/><meta name="citation_author" content="Luis A. Ortiz-Rodríguez"/><meta name="citation_author" content="Carlos E. Crespo-Hernández"/><meta name="citation_online_date" content="2020/09/22"/><meta name="citation_date" content="2020"/><meta name="citation_journal_title" content="Chemical Science"/><meta name="citation_volume" content="11"/><meta name="citation_issue" content="41"/><meta name="citation_firstpage" content="11113"/><meta name="citation_lastpage" content="11123"/><meta name="citation_doi" content="10.1039/D0SC04747C"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2020/sc/d0sc04747c"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2020/sc/d0sc04747c"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2020/sc/d0sc04747c"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-56FZ7G" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2020/sc/d0sc04747c">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:d0sc04103c)" href="/en/content/articlehtml/2020/sc/d0sc04103c" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:d0sc04542j)" href="/en/content/articlehtml/2020/sc/d0sc04542j" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div><br/><span class="oa"><img src="/content/newimages/open_access_blue.png" alt=""/> Open Access Article<br/><img src="/content/newimages/CCBY.svg" alt=""/>
This Open Access Article is licensed under a <br/><a rel="license" href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution 3.0 Unported Licence</a></span></div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/D0SC04747C">10.1039/D0SC04747C</a>
(Minireview)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/2041-6539/2010">Chem. Sci.</a></span>, 2020, <strong>11</strong>, 11113-11123</div><h1 id="sect163"><span class="title_heading">Thionated organic compounds as emerging heavy-atom-free photodynamic therapy agents</span></h1><p class="header_text">
      <span class="bold">
        
          
            Luis A. 
            Ortiz-Rodríguez
          
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Luis A. Ortiz-Rodríguez (orcid.org/0000-0002-4901-6439) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-4901-6439"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><span class="bold"> and </span>
      <span class="bold">
        
          
            Carlos E. 
            Crespo-Hernández
          
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Carlos E. Crespo-Hernández (orcid.org/0000-0002-3594-0890) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-3594-0890"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*
      <br/><span class="italic">Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106, USA. E-mail: <a href="mailto:carlos.crespo@case.edu">carlos.crespo@case.edu</a></span>
    </p><div id="art-admin"><span class="italic bold">Received 
      28th August 2020
    </span><span class="bold italic">, Accepted 15th September 2020</span></div><p class="bold italic">First published on 22nd September 2020</p><hr/><div class="abstract"><h2>Abstract</h2><p>This minireview focuses on recent progress in developing heavy-atom-free photosensitizers based on the thionation of nucleic acid derivatives and other biocompatible organic compounds for prospective applications in photodynamic therapy. Particular attention is given to the use of thionated nucleobase derivatives as “<span class="italic">one-two punch</span>” photodynamic agents. These versatile photosensitizers can act as “<span class="italic">Trojan horses</span>” upon metabolization into DNA and exposure to activating light. Their incorporation into cellular DNA increases their selectivity and photodynamic efficacy against highly proliferating skin cancer tumor cells, while simultaneously enabling the use of low irradiation doses both in the presence and in the absence of molecular oxygen. Also reviewed are their primary photochemical reactions, modes of action, and photosensitization mechanisms. New developments of emerging thionated organic photosensitizers absorbing visible and near-infrared radiation are highlighted. Future research directions, as well as, other prospective applications of heavy-atom-free, thionated photosensitizers are discussed.</p></div><hr/><table><tr><td class="biogPlate"><a href="/image/article/2020/SC/d0sc04747c/d0sc04747c-p1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0sc04747c-p1.tif" src="/image/article/2020/SC/d0sc04747c/d0sc04747c-p1.gif"/></a><p><span class="graphic_title">Luis A. Ortiz-Rodríguez</span></p></td><td><i><p>Luis A. Ortiz-Rodríguez is a Ph.D. candidate in chemistry at Case Western Reserve University. He was born in San Juan, Puerto Rico and graduated from the University of Puerto Rico-Humacao Campus, where he worked with nanosecond transient spectroscopy under the supervision of Dr. Rolando Oyola-Martínez. His graduate work focuses on understanding the excited-state dynamics of thiobases and their respective UVA-photosensitized reactions.</p></i></td></tr></table><table><tr><td class="biogPlate"><a href="/image/article/2020/SC/d0sc04747c/d0sc04747c-p2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0sc04747c-p2.tif" src="/image/article/2020/SC/d0sc04747c/d0sc04747c-p2.gif"/></a><p><span class="graphic_title">Carlos E. Crespo-Hernández</span></p></td><td><i><p>Carlos E. Crespo-Hernández received his Ph.D. in Chemistry from the University of Puerto Rico, Río Piedras Campus in 2002 under the supervision of Prof. Rafael Arce. After two years as a NIH postdoctoral fellow and one year as a Research Associate in Prof. Bern Kohler's group at The Ohio State University, he joined CWRU (2007), where he received a Frank Hovorka Assistant Professorship in Chemistry (2012–2014). He was promoted to Associate Professor in 2014 and to Professor in 2019. He is recipient of a NSF CAREER Award, the 2016 John S. Diekhoff Award for Excellence in Graduate Teaching, and the 2018 Mort Mandel Award for Outstanding Chemistry Faculty.</p></i></td></tr></table><hr/>
    
      
      <h2 id="sect203"><span class="a_heading">1. Introduction</span></h2>
      
        
        <h3 id="sect206"><span class="b_heading">1.1. Skin cancer and photodynamic therapy</span></h3>
        <span>Skin cancer is pervasive around the world.<a title="Select to navigate to reference" href="#cit1"><sup><span class="sup_ref">1–3</span></sup></a> In the USA, it is estimated that more than 3 million Americans are affected with non-melanoma skin cancers (NMSC) annually, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).<a title="Select to navigate to reference" href="#cit4"><sup><span class="sup_ref">4,5</span></sup></a> Between 1976–1984 and 2000–2010, the overall incidence of BCC increased by 145%, while it increased by 263% for SCC over the same period.<a title="Select to navigate to references" href="#cit6"><sup><span class="sup_ref">6</span></sup></a> Likewise, actinic keratosis (AK) is a common precancerous skin condition caused by DNA damage in the keratinocytes of the epidermis due to chronic exposure to sunlight. AK is of major public health concern because of its high prevalence, substantial financial impact, and potential for malignant transformation. In 2004, AK prevalence was estimated at almost 40 million in the USA, with an estimated annual cost of $1.2 billion in healthcare.<a title="Select to navigate to reference" href="#cit7"><sup><span class="sup_ref">7,8</span></sup></a> AK can develop into keratinocyte carcinoma (KC), including BCC and SCC of the skin, which are the most common cancers in the USA and in other countries with predominantly light-skinned populations. Of particular concerns are organ transplant patients who have a higher risk of AK and KC lesions than the general population due to their chronic immunosuppressed state.<a title="Select to navigate to references" href="#cit9"><sup><span class="sup_ref">9</span></sup></a> AK lesions are associated with the development of SCC, which are more aggressive, proliferate faster, and metastasize more often in organ transplant patients. It is estimated that the risk of SCC increases by up to 65–250 times in organ transplant patients compared to immunocompetent patients.<a title="Select to navigate to reference" href="#cit9"><sup><span class="sup_ref">9–11</span></sup></a></span>
        <p class="otherpara">Solar radiation is the major environmental factor in the development of BCC and SCC.<a title="Select to navigate to references" href="#cit12"><sup><span class="sup_ref">12</span></sup></a> DNA damage is directly implicated in the initiation of these cancers. In particular, the DNA cyclobutane pyrimidine dimers and (6-4) pyrimidine–pyrimidone photoproducts that are generated when DNA absorbs ultraviolet radiation are associated with mutagenesis and cancer. Individuals with xeroderma pigmentosum, a condition in which the nucleotide excision repair pathway is disabled by mutation, are unable to remove mutagenic DNA photoproducts from their skin cells and have a <span class="italic">ca.</span> 2000-fold increased rate of skin cancer in sun-exposed areas.<a title="Select to navigate to references" href="#cit13"><sup><span class="sup_ref">13</span></sup></a></p>
        <p class="otherpara">Photodynamic therapy (PDT) has key advantages over other traditional therapies such as surgery, chemotherapy, and radiotherapy for the treatment of NMSC and AK and KC lesions.<a title="Select to navigate to reference" href="#cit14"><sup><span class="sup_ref">14–17</span></sup></a> As a treatment that primarily uses a photoactivable drug (a.k.a., photosensitizer) to generate singlet oxygen and other reactive oxygen species (ROS), it offers a high degree of spatiotemporal selectivity in tumor destruction, noninvasiveness, and reduced side effects. Furthermore, it is easy to combine with other therapies. Photosensitizers are often classified as porphyrin-derived and non-porphyrin photosensitizers. Porphyrin-derived photosensitizers are classified as first, second, and third generation photosensitizers. The first generation includes hematoporphyrin derivatives and the clinically approved Photofrin®. The second generation corresponds to those porphyrin-derived photosensitizers that absorb at longer wavelengths and exhibit less skin photosensitization than their predecessors.<a title="Select to navigate to references" href="#cit18"><sup><span class="sup_ref">18</span></sup></a> When second generation photosensitizers are bound to carriers, such as antibodies to increase their accumulation into malignant tissue, they are classified as third generation photosensitizers.<a title="Select to navigate to references" href="#cit19"><sup><span class="sup_ref">19</span></sup></a> The study and development of non-porphyrin derivatives have been significantly slower. Non-porphyrin derivatives that have been investigated recently include cationic photosensitizers, such as methylene blue, toluidine blue and other chalcogenopyrilium dyes, phenothiazinium, and benzo[<span class="italic">a</span>]phenothiazinium derivatives.<a title="Select to navigate to references" href="#cit20"><sup><span class="sup_ref">20</span></sup></a></p>
        <p class="otherpara">PDT has grown in popularity in dermatology, mainly due to the easy accessibility of the skin to light exposure and the simplicity of topical use of photosensitizers. In PDT, neither the drug nor the photoactivating wavelength should have the desired therapeutic effect on its own. Once the drug accumulates in the target tissue, the photodynamic process is initiated by the localized application of radiation at wavelengths that correspond to the absorption spectrum of the photosensitizer (<span class="italic">e.g.</span>, with optical fibers). Topical PDT offers a superior cosmetic outcome than conventional therapies such as surgery, radiation therapy, and chemotherapy, which can cause serious side effects by the loss of normal cell function due to nonspecific targeting of the treatments.<a title="Select to navigate to reference" href="#cit1"><sup><span class="sup_ref">1,21</span></sup></a> PDT is approved for the treatment of wide-ranging NMSC in Europe, USA, and in other countries,<a title="Select to navigate to reference" href="#cit21"><sup><span class="sup_ref">21–23</span></sup></a> and has demonstrated high efficacy for AK, superficial and nodular BCC, squamous cell carcinoma <span class="italic">in situ</span> or Bowen's disease, and field cancerization.<a title="Select to navigate to references" href="#cit22"><sup><span class="sup_ref">22</span></sup></a> It has also been recommended for use in photo-rejuvenation, acne treatment, and other skin conditions.<a title="Select to navigate to references" href="#cit23"><sup><span class="sup_ref">23</span></sup></a></p>
        <p class="otherpara">PDT also has disadvantages. The disadvantages include severe pain and adverse reactions,<a title="Select to navigate to reference" href="#cit24"><sup><span class="sup_ref">24,25</span></sup></a> such as persistent photosensitization.<a title="Select to navigate to reference" href="#cit26"><sup><span class="sup_ref">26,27</span></sup></a> In general, the efficacy of PDT depends on the type of target cells and their oxygenation status, the photosensitizer used and its ability to penetrate the targeted diseased tissue selectively, the light source and the wavelength of light activation required, and the duration of the light-irradiation treatment. The efficacy of most clinical photosensitizers such as those discussed above strictly depends on the concentration of O<small><sub>2</sub></small> available. The PDT process itself also consumes O<small><sub>2</sub></small>, thereby effecting tumor hypoxia, which can increase the tumor's resistance to PDT.<a title="Select to navigate to reference" href="#cit28"><sup><span class="sup_ref">28,29</span></sup></a> The O<small><sub>2</sub></small> concentrations in solid tumors also vary widely by location due to the aggressive proliferation of cancer cells and insufficient blood supply, with some interior regions of the tumor exhibiting O<small><sub>2</sub></small> concentrations of less than 4% and could even decrease to 0% locally, which severely limits the efficacy of PDT against <span class="italic">in vivo</span> hypoxic tumors.<a title="Select to navigate to reference" href="#cit30"><sup><span class="sup_ref">30,31</span></sup></a> Furthermore, the photosensitizers often incorporate transition metals in their structures to increase their triplet yields. Besides poor selectivity for the target tissue, such metal complexes frequently suffer from high cytotoxicity in the absence of light activation and are often costly and difficult to synthesize.<a title="Select to navigate to reference" href="#cit32"><sup><span class="sup_ref">32–35</span></sup></a> In view of these drawbacks, there is a clinical need to develop highly selective, heavy-atom-free photodynamic agents for PDT.</p>
        <p class="otherpara">In general, to minimize the side effects, the photosensitizer should have excellent biocompatibility and photostability with no dark toxicity, large absorption coefficients in the optical window to be used for PDT, and should exhibit appropriate retention time in living tissues with relatively rapid clearance from the body.<a title="Select to navigate to reference" href="#cit36"><sup><span class="sup_ref">36,37</span></sup></a> In addition, the photosensitizer should be widely available with a high degree of chemical purity and good stability to allow for prolonged storage, and should be inexpensive and simple to synthetized.<a title="Select to navigate to references" href="#cit36"><sup><span class="sup_ref">36</span></sup></a></p>
      
      
        
        <h3 id="sect247"><span class="b_heading">1.2. Photochemical mechanisms and PDT-mediated cytotoxicity</span></h3>
        <span>Conventional PDT requires the presence and interaction of three key elements: a photosensitizer, light, and O<small><sub>2</sub></small>. As depicted in <a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>, the photosensitizer is excited to an excited singlet state (S<small><sub><span class="italic">n</span></sub></small>) upon exposure to specific wavelengths of light, which can decay radiatively or nonradiatively back to the ground state through internal conversion or can intersystem cross to the triplet manifold. The population reaching the triplet manifold usually internally converts to the lowest-energy and longer-lived triplet state (T<small><sub>1</sub></small>). Once in the T<small><sub>1</sub></small> state, the photosensitizer can react directly or indirectly with surrounding biomolecules. In a type I photosensitization mechanism, hydrogen abstraction or electron transfer between the T<small><sub>1</sub></small> state of the sensitizer and nearby biomolecule occurs, forming free radicals. The radicals may react with molecular oxygen to produce ROS such as hydrogen peroxide (H<small><sub>2</sub></small>O<small><sub>2</sub></small>), hydroxyl radical (OH˙) and superoxide anions (O<small><sub>2</sub></small>˙<small><sup>−</sup></small>). In the type II mechanism, the energy of the T<small><sub>1</sub></small> state is transferred to O<small><sub>2</sub></small> to generate singlet oxygen (<small><sup>1</sup></small>O<small><sub>2</sub></small>) and other ROS such as superoxide ions.<a title="Select to navigate to reference" href="#cit38"><sup><span class="sup_ref">38,39</span></sup></a> Dismutation or one-electron reduction of O<small><sub>2</sub></small>˙<small><sup>−</sup></small> gives hydrogen peroxide (H<small><sub>2</sub></small>O<small><sub>2</sub></small>), which in turn can undergo another one-electron reduction to form highly-oxidant hydroxyl radical species (HO˙). ROS can react with intracellular lipids, proteins, and DNA and RNA molecules to cause cell death. However, their short lifetimes (≤3.5 μs) and limited diffusion distance (≤2 μm), severely restrict their phototoxicity to the intracellular location of the photosensitizer.<a title="Select to navigate to reference" href="#cit36"><sup><span class="sup_ref">36,40,41</span></sup></a> When the photosensitizer is incorporated in DNA or RNA, its T<small><sub>1</sub></small> state can also react with an adjacent nucleobase through [2 + 2] photocycloaddition reactions and/or participate in other photocrosslinking reactions.</span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2020/SC/d0sc04747c/d0sc04747c-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0sc04747c-f1.tif" src="/image/article/2020/SC/d0sc04747c/d0sc04747c-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">(Top) Generic UVA-induced reaction mechanisms of the thiobase derivatives, which includes photocrosslinking reactions with (a) DNA or (b) proteins, and (c) triplet-energy transfer to generate molecular oxygen in its excited singlet state. Electron transfer from the triplet state of the thiobase to molecular oxygen to generate the superoxide anions and other ROS such as hydrogen peroxide and hydroxyl radicals is also possible, but not shown. These reactions can lead to cell death. (Bottom) Jabłoński electronic-energy diagram depicting the primary events leading to type I and type II photosensitized reactions, which eventually can result in oxidatively-induced cell damage. S<small><sub>0</sub></small> represents the ground electronic state of the photosensitizer, S<small><sub><span class="italic">n</span></sub></small> and T<small><sub><span class="italic">n</span></sub></small> represent upper excited singlet and triplet states, respectively, and S<small><sub>1</sub></small> and T<small><sub>1</sub></small> are the lowest-energy singlet and triplet states.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">PDT-mediated cytotoxicity occurs <span class="italic">via</span> the three main morphologies: apoptotic, necrotic and autophagy-associated cell death.<a title="Select to navigate to reference" href="#cit36"><sup><span class="sup_ref">36,42</span></sup></a> The subcellular localization of the photosensitizer in different organelles (<span class="italic">e.g.</span>, nucleus, mitochondria, lysosomes, endoplasmic reticulum, plasma membrane, <span class="italic">etc.</span>) plays a major role in the cell death mechanism that dominates, but other factors such as the overall PDT dose and the possible metabolization of the photosensitizer into cellular DNA are also important. In general, apoptosis is the principal modality of cell death when cells are treated with PDT <span class="italic">in vitro</span>.<a title="Select to navigate to references" href="#cit36"><sup><span class="sup_ref">36</span></sup></a></p>
      
    
    
      
      <h2 id="sect289"><span class="a_heading">2. Thiobases as heavy-atom-free photosensitizers: “<span class="italic">one-two punch</span>” photosensitizers to increased tumor selectivity and cellular DNA damage</span></h2>
      <span>The aim of PDT is to kill the tumor cells with minimal effects on healthy surrounding tissue. As discussed above, existing approaches have drawbacks, and there is a clinical need to develop alternatives offering improved target cell selectivity and the ability to work through more than one mechanism besides ROS generation. Site-selected sulfur-substituted nucleobases (a.k.a., thiobases) are a prospective class of heavy-atom-free organic biomolecules for clinical and cosmetic phototherapy applications,<a title="Select to navigate to reference" href="#cit43"><sup><span class="sup_ref">43–48</span></sup></a> in which a sulfur atom replaces the oxygen atom of an exocyclic carbonyl group (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>). The unique structural, biochemical, and photochemical properties of thiobases offer an attractive strategy for developing highly effective and highly targeted phototherapeutic compounds, working both in the absence and in presence of O<small><sub>2</sub></small>.<a title="Select to navigate to reference" href="#cit45"><sup><span class="sup_ref">45,47,49</span></sup></a> A single-atom-substitution converts most of the nucleobases into effective UVA chromophores (<span class="italic">ε</span> ≥ 10<small><sup>4</sup></small> M<small><sup>−1</sup></small> cm<small><sup>−1</sup></small>) that exhibit red-shifted absorption maxima from <span class="italic">ca.</span> 320 to 380 nm and with absorption bands extending all the way to the near visible region (see, for instance, <a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>).<a title="Select to navigate to reference" href="#cit49"><sup><span class="sup_ref">49,50</span></sup></a> One of most attractive applications of thiobases is for topical PDT of hyperproliferative skin conditions that are readily accessible to UVA irradiation. While thiobases have been proposed as prospective UVA photosensitizers for treatment of skin malignancies,<a title="Select to navigate to reference" href="#cit43"><sup><span class="sup_ref">43–47</span></sup></a> they are yet to be used in clinical settings.</span>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><a href="/image/article/2020/SC/d0sc04747c/d0sc04747c-f2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0sc04747c-f2.tif" src="/image/article/2020/SC/d0sc04747c/d0sc04747c-f2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">Molecular structure of the thiobases and the molar absorptivity spectra of calf thymus DNA, 4tThd, 2,4dtThy, 2,4dtUra and 2,6dtPu in PBS at pH 7.4 overlaid with depth of light penetration into fair Caucasian skin.<a title="Select to navigate to reference" href="#cit51"><sup><span class="sup_ref">51–53</span></sup></a></span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">4-Thiothymine (4tThd) is the thiobase-photosensitizer that has been studied the most and in a wider-range of cell lines and tissues. 4tThd is metabolized into DNA <span class="italic">via</span> the thymidine kinase-mediated pyrimidine nucleoside salvage pathway,<a title="Select to navigate to references" href="#cit48"><sup><span class="sup_ref">48</span></sup></a> and can effectively damage cellular DNA following exposure to nontoxic doses of UVA radiation, leading to cell death by apoptosis.<a title="Select to navigate to references" href="#cit54"><sup><span class="sup_ref">54</span></sup></a> Thymidine kinase is up-regulated during S-phase<a title="Select to navigate to references" href="#cit48"><sup><span class="sup_ref">48</span></sup></a> and is more active in rapidly dividing cells.<a title="Select to navigate to reference" href="#cit55"><sup><span class="sup_ref">55,56</span></sup></a> This property can be effectively and conveniently used for therapeutic applications, because the metabolization of nucleobase derivatives into DNA <span class="italic">via</span> pyrimidine or purine nucleoside salvage pathways is a broadly used therapeutic strategy.<a title="Select to navigate to references" href="#cit43"><sup><span class="sup_ref">43</span></sup></a> As this process is strictly dependent on phosphorylation of the nucleoside derivative by thymidine kinase, it is particularly highly active in rapidly dividing cancer cells, which exhibit very high proliferation rates compared to normal cells. Indeed, 4tThd and other thiobase derivatives has been demonstrated to be effective in treating hyperproliferative human epidermoid carcinoma cells such as SCC.<a title="Select to navigate to reference" href="#cit12"><sup><span class="sup_ref">12,45–47,57,58</span></sup></a> While 4tThd is not detectably toxic by itself in cultured human cells,<a title="Select to navigate to references" href="#cit48"><sup><span class="sup_ref">48</span></sup></a> human cell lines treated with 4tThd are killed by UVA radiation doses that are well below the doses required to cause direct cell-death or mutations.<a title="Select to navigate to references" href="#cit48"><sup><span class="sup_ref">48</span></sup></a> UVA sensitization factors of ∼100-fold can be achieved,<a title="Select to navigate to reference" href="#cit12"><sup><span class="sup_ref">12,48</span></sup></a> which seems to be largely independent of the p53 tumor suppressor status.<a title="Select to navigate to references" href="#cit12"><sup><span class="sup_ref">12</span></sup></a> Selective sensitization of rapidly dividing cells and p53 independence are both crucial properties for a treatment aimed at cancers in which p53 is often mutated or absent. The p53 tumor suppressor is a sequence-specific DNA-binding protein that is frequently mutated in human cancers and controls the expression of many genes in response to diverse stress stimuli such as UV radiation.<a title="Select to navigate to reference" href="#cit59"><sup><span class="sup_ref">59,60</span></sup></a> Low cytotoxicity of 4tThd has been confirmed in numerous human cell lines, including human fibroblasts and keratinocytes, and SCC, as well as, in rat bladder carcinoma cells.<a title="Select to navigate to reference" href="#cit12"><sup><span class="sup_ref">12,48,61</span></sup></a> 4tThd has also been shown to be a poor mutagen<a title="Select to navigate to reference" href="#cit43"><sup><span class="sup_ref">43,56</span></sup></a> and can be easily introduced into the DNA of cultured cells simply by adding it into the growth medium.</p>
      <p class="otherpara">Recent <span class="italic">in vitro</span> studies with doubly-substituted thiobases such as 2,4-dithiothymidine (2,4dtThy) and 2,6-dithiopurine (2,6dtPu) have shown superior photosensitization efficacy than 4tThd to treat human epidermoid carcinoma cells in combination with nonlethal doses of UVA radiation.<a title="Select to navigate to reference" href="#cit45"><sup><span class="sup_ref">45–47</span></sup></a> Importantly, the efficacy of 2,6dtPu in decreasing the proliferation of SCC is nearly twofold greater than that of 2,4dtThy under equal experimental conditions.<a title="Select to navigate to references" href="#cit47"><sup><span class="sup_ref">47</span></sup></a> These investigations have demonstrated that doubling thionation of the nucleobases shifts the absorption spectra to longer UVA wavelengths of light and increases the intersystem crossing rate to populate the reactive triplet state compare to 4tThd and other singly sulfur-substituted derivatives. Shifting the absorption spectrum to longer wavelengths is an important requirement for the use of thiobases in phototherapeutic applications because longer wavelengths penetrate correspondingly deeper into tissues (see, <a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>), thus allowing skin cancer cells to be treated by photoactivating thiobases at much greater depths within the dermis and epidermis of the skin.<a title="Select to navigate to reference" href="#cit51"><sup><span class="sup_ref">51–53</span></sup></a> Further investigations are require to understand whether these dithionate nucleobases are metabolized into cellular DNA and their specific modes of action.</p>
      
        
        <h3 id="sect331"><span class="b_heading">2.1. Photosensitization mechanism of thiobases</span></h3>
        <span>The mechanism by which thiobases photosensitizes induce cellular damage has not been fully elucidated,<a title="Select to navigate to references" href="#cit43"><sup><span class="sup_ref">43</span></sup></a> but 4tThd has been studied in more detail than any other thiobase currently under consideration for PDT. Importantly, photoactivation of 4tThd, as well as other thiobases,<a title="Select to navigate to references" href="#cit49"><sup><span class="sup_ref">49</span></sup></a> with UVA radiation can damage DNA through multiple mechanisms (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>).<a title="Select to navigate to reference" href="#cit45"><sup><span class="sup_ref">45,62–64</span></sup></a> In solution 4tThd generates <small><sup>1</sup></small>O<small><sub>2</sub></small> in high yields,<a title="Select to navigate to reference" href="#cit45"><sup><span class="sup_ref">45,64</span></sup></a> while its photoreactivity in DNA oligonucleotides and cellular DNA is predominantly consistent with an O<small><sub>2</sub></small>-independent mechanism.<a title="Select to navigate to reference" href="#cit56"><sup><span class="sup_ref">56,63,65</span></sup></a> The photoreactivity of 4tThd in DNA also depends sensitively on the sequence context. It has been shown to be more photoreactive when it is placed at the 3′ position of thymine, forming a DNA intrastrand crosslink with the thymine placed at the 5′ position.<a title="Select to navigate to reference" href="#cit54"><sup><span class="sup_ref">54,63</span></sup></a> Recent investigations have demonstrated that when 4tThd is incorporated in a single-stranded DNA oligonucleotide, selective photoactivation of 4tThd results in an efficient, sub-1 ps intersystem crossing to populate its reactive triplet state. A [2 + 2] photocycloaddition reaction from the triplet state of 4tThd with an adjacent thymine base in the DNA oligonucleotide leads to the population of a triplet minimum of the thietane intermediate in as short as 3 ps (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3</a>), which intersystem crosses to its ground state and rearranges to form the (6-4) photoadduct.<a title="Select to navigate to references" href="#cit63"><sup><span class="sup_ref">63</span></sup></a> Cells defective in repairing S<small><sup>5</sup></small>-(6-4) pyrimidine–pyrimidone DNA photoadducts are particularly sensitive to photodynamic treatment with 4tThd,<a title="Select to navigate to references" href="#cit56"><sup><span class="sup_ref">56</span></sup></a> which indicates that this S<small><sup>5</sup></small>-(6-4) photoadduct lesions resembling the canonical (6-4) pyrimidine-pyrimidinone photoadducts contribute significantly to the cytotoxicity. The pyrimidone moiety in the S<small><sup>5</sup></small>-(6-4) photoadduct may also act as a <span class="italic">Trojan horse</span>,<a title="Select to navigate to reference" href="#cit63"><sup><span class="sup_ref">63,66,67</span></sup></a> potentially leading to the formation of secondary cyclobutane pyrimidine dimer or oxidatively-generated damage of neighbor bases in 4tThd-containing single- and double-stranded DNA.<a title="Select to navigate to references" href="#cit63"><sup><span class="sup_ref">63</span></sup></a> Collectively, the available evidence suggests that UVA irradiation of metabolized 4tThd produces a thietane intermediate in DNA<a title="Select to navigate to reference" href="#cit56"><sup><span class="sup_ref">56,63,68</span></sup></a> upon photoreaction with a consecutive 3′-thymine base that contributes to cell death.<a title="Select to navigate to reference" href="#cit43"><sup><span class="sup_ref">43,48,56</span></sup></a> The formation of the S<small><sup>5</sup></small>-(6-4) photoadduct in DNA upon photoactivation, together with the possibility for the pyrimidinone moiety of this lesion to further absorb another UVA or UVB photon to generate further cellular DNA damage (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4</a>), is the rationale behind naming them as “<span class="italic">one-two punch</span>” photosensitizers for selective tumor cells death.</span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig3"><a href="/image/article/2020/SC/d0sc04747c/d0sc04747c-f3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0sc04747c-f3.tif" src="/image/article/2020/SC/d0sc04747c/d0sc04747c-f3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 3 </b> <span id="fig3"><span class="graphic_title">Proposed mechanism for the formation of the DNA (6-4) photoadduct in PBS at pH 7.4. A 4-thiothymine (4tT) base is highlighted with light orange in the single-stranded DNA sequence depicted to the left to imply that 4tT bases are selectively photoactivated by the UVA radiation. 4tThd and the thymidine 5′ relative to the 4tT are represented as tube in the single-stranded DNA sequence, while the other nucleobases are depicted as wireframe in order to highlight the importance of having a thymine 5′ relative to the 4tT for the reaction to occur. Figure reproduced from <a title="Select to navigate to references" href="#cit63">ref. 63</a>.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig4"><a href="/image/article/2020/SC/d0sc04747c/d0sc04747c-f4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0sc04747c-f4.tif" src="/image/article/2020/SC/d0sc04747c/d0sc04747c-f4.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 4 </b> <span id="fig4"><span class="graphic_title">Photochemistry of adjacent thymine–thymine (TpT) or thymine-4-thiothimine (Tp4tT) in DNA upon UV irradiation (modified from <a title="Select to navigate to reference" href="#cit43">ref. 43, 63 and 66</a>). Irradiation of TpT with UVC, or Tp4tT with UVA radiation, generates an oxetane or a thietane intermediate, respectively. The oxetane is highly unstable and spontaneously converts into the O<small><sup>5</sup></small>-(6-4) photoadduct (its ring-open form), whereas the thietane is more stable and exists as a 3<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1 equilibrium between the thietane and its ring-open form; the S<small><sup>5</sup></small>-(6-4) photoadduct analog. Irradiation of the ring-open forms of both O<small><sup>5</sup></small>-(6-4) photoadduct and S<small><sup>5</sup></small>-(6-4) photoadduct with UVA/B radiation can convert them into their respective Dewar isomers or can excite the pyrimidone moiety (highlight with green color) to generate further damage to DNA. Note that metabolization of 4tThd into DNA can be thought as a “Trojan horse” to photoactivate cellular damage (see, <a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>), while the formation of the S<small><sup>5</sup></small>-(6-4) photoadduct in cellular DNA can further generate DNA damage upon UVA/B excitation of its pyrimidone moiety; a “<span class="italic">one-two punch</span>” photosensitizer for increased selectivity and efficacy in PDT.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">The thietane intermediate has been shown to be in a 3<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1 equilibrium with a S<small><sup>5</sup></small>-(6-4) photoadduct lesion (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4</a>),<a title="Select to navigate to reference" href="#cit62"><sup><span class="sup_ref">62,69</span></sup></a> whereas the oxetane homolog is thought to be unstable and readily converts to its ring open form.<a title="Select to navigate to references" href="#cit43"><sup><span class="sup_ref">43</span></sup></a> The ring open forms of both the thietane and the oxetane can further convert into their Dewar valence isomer following subsequent exposure to UVA radiation. While the canonical Dewar isomers have been implicated in solar mutagenesis by UVA exposure,<a title="Select to navigate to references" href="#cit70"><sup><span class="sup_ref">70</span></sup></a> the fate of the sulfur-substituted Dewar isomers in cells is currently unknown.</p>
        <p class="otherpara">Interstrand photocrosslinking with a complementary adenine is also observed in double-stranded DNA oligonucleotides containing 4tThd after UVA radiation <span class="italic">in vivo</span>.<a title="Select to navigate to references" href="#cit56"><sup><span class="sup_ref">56</span></sup></a> This cross-linking seems to be independent of sequence, but it is less efficient when 4tThd is flanked by thymine, likely because of the competing intrastrand photocycloaddition reaction with thymine.<a title="Select to navigate to references" href="#cit56"><sup><span class="sup_ref">56</span></sup></a> As depicted in <a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>, DNA–protein crosslinks have also been detected following UVA irradiation of DNA oligonucleotides containing 4tThd<a title="Select to navigate to reference" href="#cit71"><sup><span class="sup_ref">71,72</span></sup></a> or 4tThd-treated bladder cancer cells.<a title="Select to navigate to references" href="#cit61"><sup><span class="sup_ref">61</span></sup></a> These DNA–protein crosslink lesions are difficult to repair by the DNA repair machinery and have been suggested to be a significant contributor to the cell death by apoptosis upon 4tThd-treatment following UVA irradiation.<a title="Select to navigate to references" href="#cit54"><sup><span class="sup_ref">54</span></sup></a> Double strand breaks have also been observed in 4tThd-treated cells after UVA irradiation,<a title="Select to navigate to references" href="#cit56"><sup><span class="sup_ref">56</span></sup></a> and inhibition of DNA replication by other thionated photoproducts has been reported.<a title="Select to navigate to references" href="#cit73"><sup><span class="sup_ref">73</span></sup></a></p>
        <p class="otherpara">The photosensitizing activities of 2,4dtThy, 2,4dtUra, and 2,6dtPu, three of the most promising thiobase derivatives discovered to date (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>),<a title="Select to navigate to reference" href="#cit47"><sup><span class="sup_ref">47,49</span></sup></a> have been investigated in significantly less detail than those of 4tThd. These derivatives decrease the proliferation of human epidermoid carcinoma cells by up to 63% <span class="italic">in vitro</span>, only upon activation with a low dose of UVA radiation (5 J cm<small><sup>−2</sup></small>).<a title="Select to navigate to references" href="#cit47"><sup><span class="sup_ref">47</span></sup></a> The increased efficacy of 2,6dtPu compared to 4tThd, 2,4dtThy or 2,4dtUra does not originate from an increase in dark cytotoxicity in the absence of UVA light or from an increase in the production of intracellular ROS. In fact, only a minor increase in the intracellular concentration of ROS is observed for all three thiobases following UVA activation.<a title="Select to navigate to references" href="#cit47"><sup><span class="sup_ref">47</span></sup></a> While the relative increases in ROS directly correlate with the small singlet-oxygen quantum yields measured in aqueous solution (2,4dtThy &gt; 2,6dtPu &gt; 2,4dtUra), they do not correlate with the observed photodynamic efficacies (2,6dtPu &gt; 2,4dtThy = 2,4dtUra), suggesting these dithiobases can act as effective photosensitizers within oxygen-deficient environments. Transient absorption investigations reveal the underlying photochemical properties of these thiobase derivatives in aqueous solution and rationalize the twofold enhancement of 2,6dtPu as being due to a twofold increase in its triplet-decay lifetime compared with 2,4dtThy and 2,4dtUra.<a title="Select to navigate to references" href="#cit47"><sup><span class="sup_ref">47</span></sup></a> Collectively, the nominal evidence available suggests that the excited triplet state of these doubly-substituted thiobases can participate in photocycloaddition reactions with adjacent DNA and RNA nucleobases leading to cell death, as has been demonstrated in the case of 4tThd.<a title="Select to navigate to reference" href="#cit43"><sup><span class="sup_ref">43,56,63</span></sup></a></p>
        <p class="otherpara">2,4-Dithiouracil has been shown to exhibit a threefold increased rate of photocrosslinking with adenosine monophosphate<a title="Select to navigate to references" href="#cit74"><sup><span class="sup_ref">74</span></sup></a> compare to the widely used photocrosslinking agent 4-thiouracil. Rational functionalization of these and other thiobase derivatives, aimed at increasing the magnitude of their triplet decay lifetimes and/or their two-photon absorption cross sections (see Section 4),<a title="Select to navigate to references" href="#cit49"><sup><span class="sup_ref">49</span></sup></a> is expected to further increase the photodynamic efficacy of sulfur-substituted nucleobases and expedite their application in clinical and cosmetic photodynamic therapy. In addition, further investigations are required to delineate the precise photosensitization mechanism by which these doubly-thionated nucleobase derivatives photosensitize damage to cellular DNA.</p>
        <p class="otherpara">PDT is generally associated with severe pain and reduced selectivity, even though it is not carcinogenic.<a title="Select to navigate to reference" href="#cit24"><sup><span class="sup_ref">24,25</span></sup></a> ROS are the primary mediators of the pain experience during PDT, contributing to stimulations of sensory neurons that conduct pain to the sensors on the cerebral cortex.<a title="Select to navigate to references" href="#cit75"><sup><span class="sup_ref">75</span></sup></a> Another associated factor is cell death by necrosis because immune responses such as inflammation can occur.<a title="Select to navigate to references" href="#cit75"><sup><span class="sup_ref">75</span></sup></a> Thiobase derivatives can act as “<span class="italic">Trojan horses</span>” of rapidly proliferating tumor cells, further increasing selectivity and cellular DNA/RNA damage, while simultaneously working as effective photosensitizers both in the presence and in the absence of O<small><sub>2</sub></small>. Thiobases are also expected to clear quickly from the body because similar DNA derivatives exhibit elimination half-lives of 1–10 hours,<a title="Select to navigate to references" href="#cit76"><sup><span class="sup_ref">76</span></sup></a> as opposed to the days or weeks of photosensitivity experienced with other photosensitizers.</p>
      
    
    
      
      <h2 id="sect407"><span class="a_heading">3. Second generation of heavy-atom-free photosensitizers based on thionation of organic molecules</span></h2>
      <span>Thiobases exhibit larger molar absorption coefficients at longer wavelengths, larger singlet–triplet spin–orbit coupling constants, and more efficient intersystem crossing to the triplet manifold than the corresponding carbonyl nucleobases.<a title="Select to navigate to reference" href="#cit49"><sup><span class="sup_ref">49,50,77</span></sup></a> However, one of the perceived drawbacks of using thiobases in photodynamic applications is the reduced tissue-penetrating ability of UVA radiation compared to the visible and near infrared radiation presently in use in porphyrin-based PDT.<a title="Select to navigate to references" href="#cit44"><sup><span class="sup_ref">44</span></sup></a> Hence, it seems sensible that thionation of other biocompatible organic molecules may afford heavy-atom-free photosensitizers for practical PDT applications. In 2019, Nguyen <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit78"><sup><span class="sup_ref">78</span></sup></a> demonstrated that replacing both oxygen atoms in naphthalimide derivatives with sulfur atoms to form thionaphthalimide derivatives result in enhanced intersystem crossing to reactive triplet states that can be used for PDT of HeLa cancer cells under O<small><sub>2</sub></small>-deprived (1% O<small><sub>2</sub></small>) conditions. It was also shown that the combination of thionation with the introduction of electron-donating groups could be used to increase the potential of developing photosensitizers that generate ROS <span class="italic">via</span> both type-I and type-II mechanisms at photoactivation wavelengths near the phototherapeutic window. This chemistry was further extended through the incorporation of a dual-functional morpholine group (<span class="italic">i.e.</span>, electron-donating and lysosome-targeting) into the thionaphthalimide, which was shown to generate ROS in the lysosomes of HeLa cells and to cause cell death upon light irradiation.<a title="Select to navigate to references" href="#cit79"><sup><span class="sup_ref">79</span></sup></a></span>
      <p class="otherpara">Xiao and co-workers<a title="Select to navigate to reference" href="#cit80"><sup><span class="sup_ref">80,81</span></sup></a> have recently generalized the thionation approach to design heavy-atom-free photosensitizers that can be photoactivated by visible or near-infrared light. Thionation of the carbonyl groups leads to near-unity singlet-oxygen quantum yields and large molar absorption coefficients at wavelengths as long as 760 nm (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5</a>). The developed thionated photosensitizers do not exhibit cytotoxicity in the dark, while show good photodynamic efficacy against cancer cells and 3D multicellular tumor spheroids.<a title="Select to navigate to references" href="#cit80"><sup><span class="sup_ref">80</span></sup></a> The authors further conjugated the thionated photosensitizers to the trastuzumab, a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2), to achieve tumor-specific delivery and demonstrated their tumor-specific therapeutic activity against a HER2-positive cell line. Collectively, these results indicate the promising value of thionated photosensitizers as heavy-atom-free photodynamic agents for PDT applications based on intracellular generation of ROS.<a title="Select to navigate to reference" href="#cit78"><sup><span class="sup_ref">78,79,81</span></sup></a></p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig5"><a href="/image/article/2020/SC/d0sc04747c/d0sc04747c-f5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0sc04747c-f5.tif" src="/image/article/2020/SC/d0sc04747c/d0sc04747c-f5.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 5 </b> <span id="fig5"><span class="graphic_title">Thionation of a variety of biocompatible organic compounds can dramatically enhance their abilities to generate ROS. Illustrated are structures of the starting organic compounds (left) and thionated photosensitizers (right). Reproduced from <a title="Select to navigate to references" href="#cit80">ref. 80</a>.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
    
    
      
      <h2 id="sect428"><span class="a_heading">4. Future directions and other prospective applications of thionated photosensitizers</span></h2>
      <span>The synergistic cytotoxicity of the thiobases when combined with UVA radiation has been mostly investigated in PDT for skin cancer treatment. However, PDT is established as a potent and less invasive treatment for several other cancers such as lung cancer,<a title="Select to navigate to reference" href="#cit82"><sup><span class="sup_ref">82,83</span></sup></a> esophageal cancer,<a title="Select to navigate to references" href="#cit84"><sup><span class="sup_ref">84</span></sup></a> gastric cancer,<a title="Select to navigate to references" href="#cit85"><sup><span class="sup_ref">85</span></sup></a> and cervical cancer.<a title="Select to navigate to references" href="#cit86"><sup><span class="sup_ref">86</span></sup></a> In order to perform PDT for lung cancer, for example, a bronchoscope is inserted into the airways of the patient. The bronchoscope has a small camera at one of the extremes allowing for the simultaneous visualization of the cancer and selective irradiation of the tumor cells containing the photosensitizer using low-power laser radiation. A similar procedure could be implemented to treat other types of internal cancers that are locally injected with thionated photosensitizers and exposed to laser radiation through an optical fiber. In particular, such a procedure could significantly expand the spectrum of potential uses of thiobases, as well as other biocompatible thionated photosensitizers, in PDT.</span>
      <p class="otherpara">Antimicrobial applications of PDT are now growing at a similar or faster rate than anti-cancer applications due to the widespread of multi-drug-resistance pathogenic microbes.<a title="Select to navigate to reference" href="#cit36"><sup><span class="sup_ref">36,87,88</span></sup></a> For example, antimicrobial photoinactivation is used in endodontics for antimicrobial disinfection.<a title="Select to navigate to references" href="#cit89"><sup><span class="sup_ref">89</span></sup></a> Importantly, antimicrobial photosensitizers are not restricted to have absorption bands in the visible or infrared because most of the infections to be treated are superficial in nature.<a title="Select to navigate to references" href="#cit36"><sup><span class="sup_ref">36</span></sup></a> Photoinactivation therapy is safe and relatively easy to implement and the drugs used usually rely in the generation of ROS, primarily through type II photosensitization.<a title="Select to navigate to reference" href="#cit36"><sup><span class="sup_ref">36,90</span></sup></a> This non-specificity at the target infection bypasses traditional mechanisms of resistance and minimizes the resistance to the drug itself.<a title="Select to navigate to references" href="#cit36"><sup><span class="sup_ref">36</span></sup></a> Early investigations with 4tThd have demonstrated a modest antiviral effect following UVA irradiation.<a title="Select to navigate to references" href="#cit91"><sup><span class="sup_ref">91</span></sup></a> However, to our knowledge, none of the other thionated photosensitizers discussed in this minireview have been studied as prospective antimicrobial or antiviral photodynamics agents.</p>
      <p class="otherpara">Thionated DNA and RNA derivatives, have been employed in structural biology applications since their discovery in the mid-1900s due to their photocrosslinking capabilities.<a title="Select to navigate to reference" href="#cit44"><sup><span class="sup_ref">44–46,92</span></sup></a> For example, 4-thiouracil (4tUra) has been widely used in photocrosslinking investigations to gain information about RNA–protein interactions and to uncover <span class="italic">in vivo</span> RNA structures. Pollum <span class="italic">et al.</span> showed that 2,4dtUra can outperform 4tUra in its use as a photocrosslinking agent.<a title="Select to navigate to references" href="#cit32"><sup><span class="sup_ref">32</span></sup></a> 2,4dtUra exhibits a threefold higher photocrosslinking efficiency than 4tUra at 365 nm, thus requiring shorter irradiation times and lower concentrations in photocrosslinking applications. The redshifted absorption spectrum exhibited by this thiobase (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>) compared to 4tUra, allows excitation at longer wavelengths and thus, enhancing selective excitation and increasing the depth of light penetration into tissue for <span class="italic">in vivo</span> applications.</p>
      <p class="otherpara">Finally, the use of femtosecond laser pulses to excite thiobase derivatives and other thionated photosensitizers with two visible or near-IR photons is a very attractive strategy that needs to be developed. It offers at least two benefits over direct, one-photon absorption: (1) deeper tissue penetration and (2) enhanced spatial selectivity.<a title="Select to navigate to reference" href="#cit40"><sup><span class="sup_ref">40,49</span></sup></a> Longer wavelengths of visible or near infrared radiation penetrate deeper into tissue than shorter wavelengths of light.<a title="Select to navigate to reference" href="#cit36"><sup><span class="sup_ref">36,93</span></sup></a> The need for simultaneous absorption of both photons implies that a very high photon density (of the order of GW cm<small><sup>−2</sup></small>) is required and only the photosensitizers located in the laser beam focus can be excited. Increased attention from the organic chemistry community is essential to develop thiobase derivatives and other thionated photosensitizers with enhanced two-photon absorption cross-sections.</p>
    
    
      
      <h2 id="sect454"><span class="a_heading">5. Conclusions</span></h2>
      <span>Thionation of nucleic acids and biocompatible organic compounds is a general and effective approach for developing versatile, heavy-atom-free photodynamic therapy agents. These emerging photosensitizers are expected to offer novel therapeutic approaches for the clinical management of cancers, nonmalignant conditions such as psoriasis, and possibly even for antimicrobial photoinactivation applications.</span>
      <p class="otherpara">Thionated photosensitizers are here to stay. Besides their promising use in PDT and structural-biology applications, thionated photosensitizers are expected to find a wider-range of applications such as in bioimaging, photovoltaics, and photocatalytic reactions.<a title="Select to navigate to references" href="#cit94"><sup><span class="sup_ref">94</span></sup></a></p>
    
    
      <h2 id="sect460"><span class="a_heading">Note added in proof</span></h2>
      <span>While the proofreading process of this minireview, Kim, Yoon and co-workers reported a series of sulfur-substituted naphthalimide and coumarin derivatives exhibiting negligible dark toxicity and simultaneous high phototoxicity and singlet oxygen generation toward HeLa cells and HeLa spheroids upon two-photon excitation at 800 nm.<a title="Select to navigate to references" href="#cit95"><sup><span class="sup_ref">95</span></sup></a> Indeed, diversity-oriented thioxo-1,8-naphthalimides are rapidly emerging as a versatile class of potent DNA photocleavers and promising photosensitizers for cancer therapy.<a title="Select to navigate to references" href="#cit96"><sup><span class="sup_ref">96</span></sup></a></span>
    
    
      <h2 id="sect465"><span class="a_heading">Conflicts of interest</span></h2>
      <span>There are no conflicts of interest to declare.</span>
    
  
    <h2 id="sect469"><span class="a_heading">Acknowledgements</span></h2>
      <span>The authors acknowledge the National Science Foundation (Grant No. CHE-1800052). The authors also acknowledge partial funding from the CAREER program of the National Science Foundation (Grants No. CHE-1255084 and CHE-1539808). A large number of undergraduate and graduate students, postdoctoral scholars, and collaborators have contributed to some of the research work summarized in these pages. Their efforts have been essential to the success of this research program.</span>
    
    <span id="sect471"><h2 id="sect468"><span class="a_heading">References</span></h2></span><ol type="1">
      <li><span id="cit1">B. Zhao and Y.-Y. He, <span class="italic">Expert Rev. Anticancer Ther.</span>, 2010, <span class="bold">10</span>, 1797–1809 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Expert%20Rev.%20Anticancer%20Ther.%5BJour%5D%20AND%2010%5Bvolume%5D%20AND%201797%5Bpage%5D%20and%202010%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit2">G. P. Guy, S. Machlin, D. U. Ekwueme and K. R. Yabroff, <span class="italic">Am. J. Prev. Med.</span>, 2015, <span class="bold">48</span>, 183–187 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Am.%20J.%20Prev.%20Med.%5BJour%5D%20AND%2048%5Bvolume%5D%20AND%20183%5Bpage%5D%20and%202015%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit3">
          WHO, <span class="italic">European code against cancer,</span>International Agency of Research on Cancer, Lyon,  2015 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=European%20code%20against%20cancer,%5BJour%5D%20AND%20%5Bvolume%5D%20AND%20%5Bpage%5D%20and%202015%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit4">H. W. Rogers, M. A. Weinstock, S. R. Feldman and B. M. Coldiron, <span class="italic">JAMA Dermatol.</span>, 2015, <span class="bold">151</span>, 1081–1086 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=JAMA%20Dermatol.%5BJour%5D%20AND%20151%5Bvolume%5D%20AND%201081%5Bpage%5D%20and%202015%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit5">
          American Academy of Dermatology/Milliman, <span class="italic">Burden of Skin Disease</span>, https://www.aad.org/member/clinical-quality/clinical-care/bsd, accessed  March 29, 2020 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Burden%20of%20Skin%20Disease%5BJour%5D%20AND%20%5Bvolume%5D%20AND%20%5Bpage%5D%20and%20March 29, 2020%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit6">J. G. Muzic, A. R. Schmitt, A. C. Wright, D. T. Alniemi, A. S. Zubair, J. M. O. Lourido, I. M. S. Seda, A. L. Weaver and C. L. Baum, <span class="italic">Mayo Clin. Proc.</span>, 2017, <span class="bold">92</span>, 890–898 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Mayo%20Clin.%20Proc.%5BJour%5D%20AND%2092%5Bvolume%5D%20AND%20890%5Bpage%5D%20and%202017%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit7">D. R. Bickers, H. W. Lim, D. Margolis, M. A. Weinstock, C. Goodman, E. Faulkner, C. Gould, E. Gemmen and T. Dall, <span class="italic">J. Am. Acad. Dermatol.</span>, 2006, <span class="bold">55</span>, 490–500 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Am.%20Acad.%20Dermatol.%5BJour%5D%20AND%2055%5Bvolume%5D%20AND%20490%5Bpage%5D%20and%202006%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit8">J. A. Siegel, K. Korgavkar and M. A. Weinstock, <span class="italic">Br. J. Dermatol.</span>, 2017, <span class="bold">177</span>, 350–358 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Br.%20J.%20Dermatol.%5BJour%5D%20AND%20177%5Bvolume%5D%20AND%20350%5Bpage%5D%20and%202017%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit9">M. J. Webb, J. Tomson, C. Harwood and I. Leigh, <span class="italic">Int. J. Mol. Sci.</span>, 2019, <span class="bold">20</span>, 2009 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Int.%20J.%20Mol.%20Sci.%5BJour%5D%20AND%2020%5Bvolume%5D%20AND%202009%5Bpage%5D%20and%202019%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit10">I. Bernad, L. Aguado, J. M. Núñez-Córdoba and P. Redondo, <span class="italic">J. Eur. Acad. Dermatol. Venereol.</span>, 2020, <span class="bold">34</span>, 1464–1470 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Eur.%20Acad.%20Dermatol.%20Venereol.%5BJour%5D%20AND%2034%5Bvolume%5D%20AND%201464%5Bpage%5D%20and%202020%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit11">S. Euvrard, J. Kanitakis and A. Claudy, <span class="italic">N. Engl. J. Med.</span>, 2003, <span class="bold">348</span>, 1681–1691 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=N.%20Engl.%20J.%20Med.%5BJour%5D%20AND%20348%5Bvolume%5D%20AND%201681%5Bpage%5D%20and%202003%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit12">O. Reelfs, Y.-Z. Xu, A. Massey, P. Karran and A. Storey, <span class="italic">Mol. Cancer Ther.</span>, 2007, <span class="bold">6</span>, 2487–2495 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Mol.%20Cancer%20Ther.%5BJour%5D%20AND%206%5Bvolume%5D%20AND%202487%5Bpage%5D%20and%202007%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit13">K. H. Kraemer, M. M. Lee and J. Scotto, <span class="italic">Arch. Dermatol.</span>, 1987, <span class="bold">123</span>, 241–250 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Arch.%20Dermatol.%5BJour%5D%20AND%20123%5Bvolume%5D%20AND%20241%5Bpage%5D%20and%201987%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit14">D. E. J. G. J. Dolmans, D. Fukumura and R. K. Jain, <span class="italic">Nat. Rev. Cancer</span>, 2003, <span class="bold">3</span>, 380–387 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Nat.%20Rev.%20Cancer%5BJour%5D%20AND%203%5Bvolume%5D%20AND%20380%5Bpage%5D%20and%202003%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit15">S. B. Brown, E. A. Brown and I. Walker, <span class="italic">Lancet Oncol.</span>, 2004, <span class="bold">5</span>, 497–508 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Lancet%20Oncol.%5BJour%5D%20AND%205%5Bvolume%5D%20AND%20497%5Bpage%5D%20and%202004%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit16">A. P. Castano, P. Mroz and M. R. Hamblin, <span class="italic">Nat. Rev. Cancer</span>, 2006, <span class="bold">6</span>, 535–545 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Nat.%20Rev.%20Cancer%5BJour%5D%20AND%206%5Bvolume%5D%20AND%20535%5Bpage%5D%20and%202006%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit17">W. Fan, P. Huang and X. Chen, <span class="italic">Chem. Soc. Rev.</span>, 2016, <span class="bold">45</span>, 6488–6519 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Chem.%20Soc.%20Rev.%5BJour%5D%20AND%2045%5Bvolume%5D%20AND%206488%5Bpage%5D%20and%202016%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit18">C. S. Nayak, <span class="italic">Indian J. Dermatol. Venereol. Leprol.</span>, 2005, <span class="bold">71</span>, 155–160 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Indian%20J.%20Dermatol.%20Venereol.%20Leprol.%5BJour%5D%20AND%2071%5Bvolume%5D%20AND%20155%5Bpage%5D%20and%202005%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit19">A. Juzeniene, Q. Peng and J. Moan, <span class="italic">Photochem. Photobiol. Sci.</span>, 2007, <span class="bold">6</span>, 1234–1245 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photochem.%20Photobiol.%20Sci.%5BJour%5D%20AND%206%5Bvolume%5D%20AND%201234%5Bpage%5D%20and%202007%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit20">K. A. Leonard, M. I. Nelen, T. P. Simard, S. R. Davies, S. O. Gollnick, A. R. Oseroff, S. L. Gibson, R. Hilf, L. B. Chen and M. R. Detty, <span class="italic">J. Med. Chem.</span>, 1999, <span class="bold">42</span>, 3953–3964 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Med.%20Chem.%5BJour%5D%20AND%2042%5Bvolume%5D%20AND%203953%5Bpage%5D%20and%201999%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit21">C. A. Morton, R.-M. Szeimies, A. Sidoroff and L. R. Brathen, <span class="italic">J. Eur. Acad. Dermatol. Venereol.</span>, 2013, <span class="bold">27</span>, 536–544 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Eur.%20Acad.%20Dermatol.%20Venereol.%5BJour%5D%20AND%2027%5Bvolume%5D%20AND%20536%5Bpage%5D%20and%202013%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit22">C. A. Morton, R.-M. Szeimies, N. Basset-Seguin, P. G. Calzavara-Pinton, Y. Gilaberte, M. Haedersdal, G. F. L. Hofbauer, R. E. Hunger, S. Karrer, S. Piaserico, C. Ulrich, A.-M. Wennberg and L. R. Braathen, <span class="italic">J. Eur. Acad. Dermatol. Venereol.</span>, 2019, <span class="bold">13</span>, 2225–2238 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Eur.%20Acad.%20Dermatol.%20Venereol.%5BJour%5D%20AND%2013%5Bvolume%5D%20AND%202225%5Bpage%5D%20and%202019%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit23">C. A. Morton, R.-M. Szeimies, N. Basset-Séguin, P. G. Calzavara-Pinton, Y. Gilaberte, M. Haedersdal, G. F. L. Hofbauer, R. E. Hunger, S. Karrer, S. Piaserico, C. Ulrich, A.-M. Wennberg and L. R. Braathen, <span class="italic">J. Eur. Acad. Dermatol. Venereol.</span>, 2020, <span class="bold">34</span>, 17–29 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Eur.%20Acad.%20Dermatol.%20Venereol.%5BJour%5D%20AND%2034%5Bvolume%5D%20AND%2017%5Bpage%5D%20and%202020%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit24">S. K. Attili, R. Dawe and S. Ibbotson, <span class="italic">Photodiagn. Photodyn. Ther.</span>, 2011, <span class="bold">8</span>, 53–57 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photodiagn.%20Photodyn.%20Ther.%5BJour%5D%20AND%208%5Bvolume%5D%20AND%2053%5Bpage%5D%20and%202011%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit25">S. Ibbotson, <span class="italic">Photodermatol., Photoimmunol. Photomed.</span>, 2011, <span class="bold">27</span>, 116–130 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photodermatol.,%20Photoimmunol.%20Photomed.%5BJour%5D%20AND%2027%5Bvolume%5D%20AND%20116%5Bpage%5D%20and%202011%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit26">A. M. Bugaj, <span class="italic">Photochem. Photobiol. Sci.</span>, 2011, <span class="bold">10</span>, 1097–1109 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photochem.%20Photobiol.%20Sci.%5BJour%5D%20AND%2010%5Bvolume%5D%20AND%201097%5Bpage%5D%20and%202011%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit27">M. Verhille, P. Couleaud, R. Vanderesse, D. Brault, M. Barberi-Heyob and C. Frochot, <span class="italic">Curr. Med. Chem.</span>, 2010, <span class="bold">17</span>, 3925–3943 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Curr.%20Med.%20Chem.%5BJour%5D%20AND%2017%5Bvolume%5D%20AND%203925%5Bpage%5D%20and%202010%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit28">M. Höckel and P. Vaupel, <span class="italic">J. Natl. Cancer Inst.</span>, 2001, <span class="bold">93</span>, 266–276 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Natl.%20Cancer%20Inst.%5BJour%5D%20AND%2093%5Bvolume%5D%20AND%20266%5Bpage%5D%20and%202001%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit29">P. Vaupel, M. Höckel and A. Mayer, <span class="italic">Antioxid. Redox Signaling</span>, 2007, <span class="bold">9</span>, 1221–1236 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Antioxid.%20Redox%20Signaling%5BJour%5D%20AND%209%5Bvolume%5D%20AND%201221%5Bpage%5D%20and%202007%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit30">J. M. Brown and W. R. Wilson, <span class="italic">Nat. Rev. Cancer</span>, 2004, <span class="bold">4</span>, 437–447 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Nat.%20Rev.%20Cancer%5BJour%5D%20AND%204%5Bvolume%5D%20AND%20437%5Bpage%5D%20and%202004%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit31">W. R. Wilson and M. P. Hay, <span class="italic">Nat. Rev. Cancer</span>, 2011, <span class="bold">11</span>, 393–410 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Nat.%20Rev.%20Cancer%5BJour%5D%20AND%2011%5Bvolume%5D%20AND%20393%5Bpage%5D%20and%202011%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit32">P. C. A. Bruijnincx and P. J. Sadler, <span class="italic">Adv. Inorg. Chem.</span>, 2009, <span class="bold">61</span>, 1–62 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Adv.%20Inorg.%20Chem.%5BJour%5D%20AND%2061%5Bvolume%5D%20AND%201%5Bpage%5D%20and%202009%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit33">N. A. Smith and P. J. Sadler, <span class="italic">Philos. Trans. R. Soc., A</span>, 2013, <span class="bold">371</span>, 20120519 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Philos.%20Trans.%20R.%20Soc.,%20A%5BJour%5D%20AND%20371%5Bvolume%5D%20AND%2020120519%5Bpage%5D%20and%202013%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit34">F. Schmitt, P. Govindaswamy, G. Süss-Fink, W. H. Ang, P. J. Dyson, L. Juillerat-Jeanneret and B. Therrien, <span class="italic">J. Med. Chem.</span>, 2008, <span class="bold">51</span>, 1811–1816 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Med.%20Chem.%5BJour%5D%20AND%2051%5Bvolume%5D%20AND%201811%5Bpage%5D%20and%202008%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit35">S. Monro, K. L. Colón, H. Yin, J. Roque III, P. Konda, S. Gujar, R. P. Thummel, L. Lilge, C. G. Cameron and S. A. McFarland, <span class="italic">Chem. Rev.</span>, 2019, <span class="bold">119</span>, 797–828 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Chem.%20Rev.%5BJour%5D%20AND%20119%5Bvolume%5D%20AND%20797%5Bpage%5D%20and%202019%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit36">H. Abrahamse and M. R. Hamblin, <span class="italic">Biochem. J.</span>, 2016, <span class="bold">473</span>, 347–364 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Biochem.%20J.%5BJour%5D%20AND%20473%5Bvolume%5D%20AND%20347%5Bpage%5D%20and%202016%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit37">R. R. Allison and C. H. Sibata, <span class="italic">Photodiagn. Photodyn. Ther.</span>, 2010, <span class="bold">7</span>, 61–75 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photodiagn.%20Photodyn.%20Ther.%5BJour%5D%20AND%207%5Bvolume%5D%20AND%2061%5Bpage%5D%20and%202010%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit38">C. S. Foote, <span class="italic">Photochem. Photobiol.</span>, 1991, <span class="bold">54</span>, 659–671 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photochem.%20Photobiol.%5BJour%5D%20AND%2054%5Bvolume%5D%20AND%20659%5Bpage%5D%20and%201991%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit39">M. S. Baptista, J. Cadet, P. Di Mascio, A. A. Ghogare, A. Greer, M. R. Hamblin, C. Lorente, S. C. Nunez, M. S. Ribeiro, A. H. Thomas, M. Vignoni and T. M. Yoshimura, <span class="italic">Photochem. Photobiol.</span>, 2017, <span class="bold">93</span>, 912–919 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photochem.%20Photobiol.%5BJour%5D%20AND%2093%5Bvolume%5D%20AND%20912%5Bpage%5D%20and%202017%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit40">M. Lan, S. Zhao, W. Liu, C.-S. Lee, W. Zhang and P. Wang, <span class="italic">Adv. Healthcare Mater.</span>, 2019, <span class="bold">8</span>, 1900132 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Adv.%20Healthcare%20Mater.%5BJour%5D%20AND%208%5Bvolume%5D%20AND%201900132%5Bpage%5D%20and%202019%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit41">J. S. Dysart and M. S. Patterson, <span class="italic">Phys. Med. Biol.</span>, 2005, <span class="bold">50</span>, 2597–2616 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Phys.%20Med.%20Biol.%5BJour%5D%20AND%2050%5Bvolume%5D%20AND%202597%5Bpage%5D%20and%202005%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit42">D. Kessel and N. L. Oleinick, <span class="italic">Photochem. Photobiol.</span>, 2018, <span class="bold">94</span>, 213–218 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photochem.%20Photobiol.%5BJour%5D%20AND%2094%5Bvolume%5D%20AND%20213%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit43">O. Reelfs, P. Karran and A. R. Young, <span class="italic">Photochem. Photobiol. Sci.</span>, 2012, <span class="bold">11</span>, 148–154 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photochem.%20Photobiol.%20Sci.%5BJour%5D%20AND%2011%5Bvolume%5D%20AND%20148%5Bpage%5D%20and%202012%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit44">E. Gemenetzidis, O. Shavorskaya, Y.-Z. Xu and G. Trigiante, <span class="italic">J. Dermatol. Treat.</span>, 2013, <span class="bold">24</span>, 209–214 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Dermatol.%20Treat.%5BJour%5D%20AND%2024%5Bvolume%5D%20AND%20209%5Bpage%5D%20and%202013%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit45">M. Pollum, S. Jockusch and C. E. Crespo-Hernández, <span class="italic">J. Am. Chem. Soc.</span>, 2014, <span class="bold">136</span>, 17930–17933 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Am.%20Chem.%20Soc.%5BJour%5D%20AND%20136%5Bvolume%5D%20AND%2017930%5Bpage%5D%20and%202014%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit46">M. Pollum, L. Guan, S. Ahsanuddin, E. Baron, M. Lam and C. Crespo-Hernández, <span class="italic">J. Invest. Dermatol.</span>, 2016, <span class="bold">136</span>, S105 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Invest.%20Dermatol.%5BJour%5D%20AND%20136%5Bvolume%5D%20AND%20S105%5Bpage%5D%20and%202016%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit47">M. Pollum, L. Minh, S. Jockusch and C. E. Crespo-Hernández, <span class="italic">ChemMedChem</span>, 2018, <span class="bold">13</span>, 1044–1050 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=ChemMedChem%5BJour%5D%20AND%2013%5Bvolume%5D%20AND%201044%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit48">A. Massey, Y.-Z. Xu and P. Karran, <span class="italic">Curr. Biol.</span>, 2001, <span class="bold">11</span>, 1142–1146 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Curr.%20Biol.%5BJour%5D%20AND%2011%5Bvolume%5D%20AND%201142%5Bpage%5D%20and%202001%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit49">B. Ashwood, M. Pollum and C. E. Crespo-Hernández, <span class="italic">Photochem. Photobiol.</span>, 2019, <span class="bold">95</span>, 33–58 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photochem.%20Photobiol.%5BJour%5D%20AND%2095%5Bvolume%5D%20AND%2033%5Bpage%5D%20and%202019%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit50">
          M. Pollum, L. Martínez-Fernández and C. E. Crespo-Hernández, in <span class="italic">Photoinduced Phenomena in Nucleic Acids I</span>, ed. M. Barbatti, A. C. Borin and S. Ullrich, Springer, Cham, Switzerland,  2015, vol. 355, pp. 245–327 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photoinduced%20Phenomena%20in%20Nucleic%20Acids%20I%5BJour%5D%20AND%20vol. 355%5Bvolume%5D%20AND%20%5Bpage%5D%20and%202015%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit51">M. J. C. van Gemert and A. J. Welch, <span class="italic">IEEE Eng. Med. Biol.</span>, 1989, <span class="bold">89</span>, 10–13 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=IEEE%20Eng.%20Med.%20Biol.%5BJour%5D%20AND%2089%5Bvolume%5D%20AND%2010%5Bpage%5D%20and%201989%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit52">Q. Peng, A. Juzeniene, J. Chen, L. O. Svaasand, T. Warloe, K.-E. Giercksky and J. Moan, <span class="italic">Rep. Prog. Phys.</span>, 2008, <span class="bold">71</span>, 056701–056728 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Rep.%20Prog.%20Phys.%5BJour%5D%20AND%2071%5Bvolume%5D%20AND%20056701%5Bpage%5D%20and%202008%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit53">R. R. Anderson, B. S. Parrish and J. A. Parrish, <span class="italic">J. Invest. Dermatol.</span>, 1981, <span class="bold">77</span>, 13–19 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Invest.%20Dermatol.%5BJour%5D%20AND%2077%5Bvolume%5D%20AND%2013%5Bpage%5D%20and%201981%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit54">R. Brem, M. Guven and P. Karran, <span class="italic">Free Radical Biol. Med.</span>, 2017, <span class="bold">107</span>, 101–109 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Free%20Radical%20Biol.%20Med.%5BJour%5D%20AND%20107%5Bvolume%5D%20AND%20101%5Bpage%5D%20and%202017%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit55">M. Hengstschlager, M. Pfeilstocker and E. Wawra, <span class="italic">Adv. Exp. Med. Biol.</span>, 1998, <span class="bold">431</span>, 455–460 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Adv.%20Exp.%20Med.%20Biol.%5BJour%5D%20AND%20431%5Bvolume%5D%20AND%20455%5Bpage%5D%20and%201998%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit56">O. Reelfs, P. Macpherson, X. Ren, Y.-Z. Xu, P. Karran and A. R. Young, <span class="italic">Nucleic Acids Res.</span>, 2011, <span class="bold">39</span>, 9620–9632 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Nucleic%20Acids%20Res.%5BJour%5D%20AND%2039%5Bvolume%5D%20AND%209620%5Bpage%5D%20and%202011%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit57">M. H. al-Sader, E. Doyle, E. W. Kay, M. Bennett, C. B. Walsh, C. Milburn and M. Leader, <span class="italic">J. Clin. Pathol.</span>, 1996, <span class="bold">49</span>, 549–551 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Clin.%20Pathol.%5BJour%5D%20AND%2049%5Bvolume%5D%20AND%20549%5Bpage%5D%20and%201996%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit58">M. Pollum, B. Ashwood, S. Jockusch, M. Lam and C. E. Crespo-Hernández, <span class="italic">J. Am. Chem. Soc.</span>, 2016, <span class="bold">138</span>, 11457–11460 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Am.%20Chem.%20Soc.%5BJour%5D%20AND%20138%5Bvolume%5D%20AND%2011457%5Bpage%5D%20and%202016%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit59">S. Kanjilal, W. E. Pierceall, K. K. Cummings, M. L. Kripke and H. N. Ananthaswamy, <span class="italic">Cancer Res.</span>, 1993, <span class="bold">53</span>, 2961–2964 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Cancer%20Res.%5BJour%5D%20AND%2053%5Bvolume%5D%20AND%202961%5Bpage%5D%20and%201993%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit60">L. Latonen, Y. Taya and M. Laiho, <span class="italic">Oncogene</span>, 2001, <span class="bold">20</span>, 6784–6793 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Oncogene%5BJour%5D%20AND%2020%5Bvolume%5D%20AND%206784%5Bpage%5D%20and%202001%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit61">S. W. Pridgeon, R. Heer, G. A. Taylor, D. R. Newell, K. O'Toole, M. Robinson, U.-Z. Xu, P. Karran and A. V. Boddly, <span class="italic">Br. J. Cancer</span>, 2011, <span class="bold">104</span>, 1869–1876 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Br.%20J.%20Cancer%5BJour%5D%20AND%20104%5Bvolume%5D%20AND%201869%5Bpage%5D%20and%202011%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit62">P. Clivio, J. L. Fourrey, J. Gasche and A. Favre, <span class="italic">J. Am. Chem. Soc.</span>, 1991, <span class="bold">113</span>, 5481–5483 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Am.%20Chem.%20Soc.%5BJour%5D%20AND%20113%5Bvolume%5D%20AND%205481%5Bpage%5D%20and%201991%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit63">L. A. Ortiz-Rodríguez, C. Reichardt, S. J. Hoehn, S. Jockusch and C. E. Crespo-Hernández, <span class="italic">Nat. Commun.</span>, 2020, <span class="bold">11</span>, 3599 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Nat.%20Commun.%5BJour%5D%20AND%2011%5Bvolume%5D%20AND%203599%5Bpage%5D%20and%202020%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit64">Y. Harada, T. Suzuki, T. Ichimura and Y.-Z. Xu, <span class="italic">J. Phys. Chem. B</span>, 2007, <span class="bold">111</span>, 5518–5524 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Phys.%20Chem.%20B%5BJour%5D%20AND%20111%5Bvolume%5D%20AND%205518%5Bpage%5D%20and%202007%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit65">M. A. Warren, J. B. Murray and B. A. Connolly, <span class="italic">J. Mol. Biol.</span>, 1998, <span class="bold">279</span>, 89–100 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Mol.%20Biol.%5BJour%5D%20AND%20279%5Bvolume%5D%20AND%2089%5Bpage%5D%20and%201998%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit66">V. Vendrell-Criado, G. M. Rodrígues-Muñiz, M. C. Cuquerella, V. Lhiaubet-Vallet and M. A. Miranda, <span class="italic">Angew. Chem., Int. Ed.</span>, 2013, <span class="bold">125</span>, 6604–6607 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Angew.%20Chem.,%20Int.%20Ed.%5BJour%5D%20AND%20125%5Bvolume%5D%20AND%206604%5Bpage%5D%20and%202013%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit67">V. Vendrell-Criado, G. M. Rodrígues-Muñiz, M. C. Cuquerella, V. Lhiaubet-Vallet and M. A. Miranda, <span class="italic">ChemPhysChem</span>, 2016, <span class="bold">17</span>, 1979–1982 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=ChemPhysChem%5BJour%5D%20AND%2017%5Bvolume%5D%20AND%201979%5Bpage%5D%20and%202016%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit68">B. A. Connolly and P. C. Newman, <span class="italic">Nucleic Acids Res.</span>, 1989, <span class="bold">17</span>, 4957–4974 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Nucleic%20Acids%20Res.%5BJour%5D%20AND%2017%5Bvolume%5D%20AND%204957%5Bpage%5D%20and%201989%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit69">P. Clivio, J. L. Fourrey and J. Gasche, <span class="italic">Tetrahedron Lett.</span>, 1992, <span class="bold">33</span>, 1615–1618 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Tetrahedron%20Lett.%5BJour%5D%20AND%2033%5Bvolume%5D%20AND%201615%5Bpage%5D%20and%201992%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit70">D. Perdiz, P. Grof, M. Mezzina, O. Nikaido, E. Moustacchi and E. Sage, <span class="italic">J. Biol. Chem.</span>, 2000, <span class="bold">275</span>, 26732–26742 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Biol.%20Chem.%5BJour%5D%20AND%20275%5Bvolume%5D%20AND%2026732%5Bpage%5D%20and%202000%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit71">T. T. Nikiforov and B. A. Connolly, <span class="italic">Nucleic Acids Res.</span>, 1992, <span class="bold">20</span>, 1209–1214 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Nucleic%20Acids%20Res.%5BJour%5D%20AND%2020%5Bvolume%5D%20AND%201209%5Bpage%5D%20and%201992%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit72">B. Bartholomew, B. R. Braun, G. A. Kassavetis and E. P. Geiduschek, <span class="italic">J. Biol. Chem.</span>, 1994, <span class="bold">269</span>, 18090–18095 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Biol.%20Chem.%5BJour%5D%20AND%20269%5Bvolume%5D%20AND%2018090%5Bpage%5D%20and%201994%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit73">A. Ito, F. T. Robb and J. G. Peak, <span class="italic">Photochem. Photobiol.</span>, 1988, <span class="bold">47</span>, 231–240 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photochem.%20Photobiol.%5BJour%5D%20AND%2047%5Bvolume%5D%20AND%20231%5Bpage%5D%20and%201988%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit74">M. Pollum, S. Jockusch and C. E. Crespo-Hernández, <span class="italic">Phys. Chem. Chem. Phys.</span>, 2015, <span class="bold">17</span>, 27851–27861 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Phys.%20Chem.%20Chem.%20Phys.%5BJour%5D%20AND%2017%5Bvolume%5D%20AND%2027851%5Bpage%5D%20and%202015%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit75">F. Borgia, R. Giuffrida, E. Caradonna, M. Vaccaro, F. Guarneri and S. P. Cannavò, <span class="italic">Biomedicines</span>, 2018, <span class="bold">6</span>, 12 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Biomedicines%5BJour%5D%20AND%206%5Bvolume%5D%20AND%2012%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit76">H. Someya, W. R. Waud and W. B. Parker, <span class="italic">Cancer Chemother. Pharmacol.</span>, 2006, <span class="bold">57</span>, 772–780 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Cancer%20Chemother.%20Pharmacol.%5BJour%5D%20AND%2057%5Bvolume%5D%20AND%20772%5Bpage%5D%20and%202006%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit77">S. Mai, M. Pollum, L. Martínez-Fernández, N. Dunn, P. Marquetand, I. Corral, C. E. Crespo-Hernández and L. González, <span class="italic">Nat. Commun.</span>, 2016, <span class="bold">7</span>, 13077 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Nat.%20Commun.%5BJour%5D%20AND%207%5Bvolume%5D%20AND%2013077%5Bpage%5D%20and%202016%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit78">V.-N. Nguyen, S. Qi, S. Kim, N. Kwon, G. Kim, Y. Yim, S. Park and J. Yoon, <span class="italic">J. Am. Chem. Soc.</span>, 2019, <span class="bold">141</span>, 16243–16248 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Am.%20Chem.%20Soc.%5BJour%5D%20AND%20141%5Bvolume%5D%20AND%2016243%5Bpage%5D%20and%202019%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit79">V.-N. Nguyen, G. Baek, S. Qi, S. Heo, Y. Yim and J. Yoon, <span class="italic">Dyes Pigm.</span>, 2020, <span class="bold">177</span>, 108265 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Dyes%20Pigm.%5BJour%5D%20AND%20177%5Bvolume%5D%20AND%20108265%5Bpage%5D%20and%202020%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit80">J. Tang, L. Wang, A. Loredo, C. Cole and H. Xiao, <span class="italic">Chem. Sci.</span>, 2020, <span class="bold">11</span>, 6701–6708 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Chem.%20Sci.%5BJour%5D%20AND%2011%5Bvolume%5D%20AND%206701%5Bpage%5D%20and%202020%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit81">J. Tang, M. A. Robichaux, K.-L. Wu, J. Pei, V.-N. Nguyen, Y. Zhou, T. G. Wensel and H. Xiao, <span class="italic">J. Am. Chem. Soc.</span>, 2019, <span class="bold">141</span>, 14699–14706 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Am.%20Chem.%20Soc.%5BJour%5D%20AND%20141%5Bvolume%5D%20AND%2014699%5Bpage%5D%20and%202019%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit82">J. Usada, H. Kato, T. Okunaka, K. Furukawa, H. Tsutsui, K. Yamada, Y. Suga, H. Honda, Y. Nagatsuka, T. Ohira, M. Tsuboi and T. Hirano, <span class="italic">J. Thorac. Oncol.</span>, 2006, <span class="bold">1</span>, 489–493 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Thorac.%20Oncol.%5BJour%5D%20AND%201%5Bvolume%5D%20AND%20489%5Bpage%5D%20and%202006%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit83">J.-M. Vergnon, R. M. Huber and K. Moghissi, <span class="italic">Eur. Respir. J.</span>, 2006, <span class="bold">28</span>, 200–218 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Eur.%20Respir.%20J.%5BJour%5D%20AND%2028%5Bvolume%5D%20AND%20200%5Bpage%5D%20and%202006%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit84">T. Yano, K. Hatogai, H. Morimoto, Y. Yoda and K. Kaneko, <span class="italic">Ann. Transl. Med.</span>, 2014, <span class="bold">2</span>, 2–5 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Ann.%20Transl.%20Med.%5BJour%5D%20AND%202%5Bvolume%5D%20AND%202%5Bpage%5D%20and%202014%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit85">L. Gossner and C. Ell, <span class="italic">Gastrointest. Endosc. Clin.</span>, 2000, <span class="bold">10</span>, 461–480 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Gastrointest.%20Endosc.%20Clin.%5BJour%5D%20AND%2010%5Bvolume%5D%20AND%20461%5Bpage%5D%20and%202000%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit86">
          Y. Muroya,  1995.</span></li>
      <li><span id="cit87">M. Wainwright, T. Maisch, S. Nonell, K. Plaetzer, A. Almeida, G. P. Tegos and M. R. Hamblin, <span class="italic">Lancet Infect. Dis.</span>, 2017, <span class="bold">17</span>, e49–355 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Lancet%20Infect.%20Dis.%5BJour%5D%20AND%2017%5Bvolume%5D%20AND%20e49%5Bpage%5D%20and%202017%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit88">M. R. Hamblin and T. Hasan, <span class="italic">Photochem. Photobiol. Sci.</span>, 2004, <span class="bold">3</span>, 436–450 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photochem.%20Photobiol.%20Sci.%5BJour%5D%20AND%203%5Bvolume%5D%20AND%20436%5Bpage%5D%20and%202004%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit89">M. Plotino, G. Grande and N. M. Mercade, <span class="italic">Int. Endod. J.</span>, 2019, <span class="bold">52</span>, 760–774 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Int.%20Endod.%20J.%5BJour%5D%20AND%2052%5Bvolume%5D%20AND%20760%5Bpage%5D%20and%202019%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit90">K. Konopka and T. Goslinski, <span class="italic">J. Dent. Res.</span>, 2007, <span class="bold">86</span>, 694–707 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Dent.%20Res.%5BJour%5D%20AND%2086%5Bvolume%5D%20AND%20694%5Bpage%5D%20and%202007%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit91">A. Domi, M. Siromachkova, J. L. Fourrey, A. Favre and G. Beaud, <span class="italic">Photochem. Photobiol.</span>, 1995, <span class="bold">61</span>, 463–470 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photochem.%20Photobiol.%5BJour%5D%20AND%2061%5Bvolume%5D%20AND%20463%5Bpage%5D%20and%201995%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit92">N. I. Rechkunova and O. I. Lavrik, <span class="italic">Photochem. Photobiol.</span>, 2020, <span class="bold">96</span>, 440–449 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photochem.%20Photobiol.%5BJour%5D%20AND%2096%5Bvolume%5D%20AND%20440%5Bpage%5D%20and%202020%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit93">A. Aggarwal, S. Thompson, S. Singh, B. Newton, A. Moore, R. Gao, X. Gu, S. Mukherjee and C. M. Drain, <span class="italic">Photochem. Photobiol.</span>, 2014, <span class="bold">90</span>, 419–430 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Photochem.%20Photobiol.%5BJour%5D%20AND%2090%5Bvolume%5D%20AND%20419%5Bpage%5D%20and%202014%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit94">G. C. Hoover and D. S. Seferos, <span class="italic">Chem. Sci.</span>, 2019, <span class="bold">10</span>, 9182–9188 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Chem.%20Sci.%5BJour%5D%20AND%2010%5Bvolume%5D%20AND%209182%5Bpage%5D%20and%202019%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit95">V.-N. Nguyen, S. J. Park, S. Qi, J. Ha, S. Heo, Y. Yim, G. Baek, C. S. Lim, D. J. Lee, H. M. Kim and J. Yoon, <span class="italic">Chem. Commun.</span>, 2020 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=d1030cc04644b&amp;newsite=1" title="Link to RSC resource DOI:10.1039/d1030cc04644b"><small>10.1039/d1030cc04644b</small></a>.</span></li>
      <li><span id="cit96">X. Luo, Y. Yang and X. Qian, <span class="italic">Chin. Chem. Lett.</span>, 2020<small> DOI:<a class="DOILink" href="https://doi.org/10.1016/j.cclet.2020.1007.1009" TARGET="_BLANK" title="DOI Link to 10.1016/j.cclet.2020.1007.1009">10.1016/j.cclet.2020.1007.1009</a></small>.</span></li>
    </ol>
    
    
    
    
    
  <table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2020</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>